Could removing metals from blood help fight leukemia?
NCT ID NCT06811233
Summary
This study is testing whether adding metal detoxification to standard chemotherapy helps control acute myeloid leukemia (AML) better than chemotherapy alone. Researchers will give 140 adults with intermediate or high-risk AML either standard treatment plus metal-removing drugs (Ca-EDTA and DMSA) or just standard treatment. They want to see if lowering metal levels in the blood and bone marrow helps the chemotherapy work better and improves survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas M. D. Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.